Our cellular experiments in the present study further confirmed that the knockdown of FDX1 not only reduced elesclomol-Cu-induced DLAT oligomerization but also conferred resistance to copper-induced cell death in HCC cells. The gene discussed is FDX1; the disease is hepatocellular carcinoma.